StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) income statement

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06+0.00 (0.00%)

Close on Nov 20, 2026Market cap $13.96MP/E –Yield –

See a number that looks wrong?